Clinical Impact Of Early Progression Among Patients (Pts) With Metastatic Renal Cell Carcinoma (Mrcc) Treated With Tyrosine Kinase Inhibitors (Tkis) In First-Line (1l) Setting: Impact Rcc Real-World Study.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要